Nanoscope Therapeutics to Participate in Advanced Therapies USA 2026 in Boston
Co-Founder, CEO Sulagna Bhattacharya to join Keynote Panel on navigating the cell and gene therapy landscape and driving market successCo-Founder,...
Co-Founder, CEO Sulagna Bhattacharya to join Keynote Panel on navigating the cell and gene therapy landscape and driving market successCo-Founder,...
Co-Founder, CEO Sulagna Bhattacharya to join Keynote Panel on navigating the cell and gene therapy landscape and driving market successCo-Founder,...
Etcelera unites the platform technologies of Cellarity, Etiome, and Empress Therapeutics with Flagship Pioneering's proprietary AI capabilities to scale causal...
Nationwide testing, affordable and transparent pricing, and easy-to-use software simplify DOT drug and alcohol compliance.CHICAGO, Oct. 29, 2026 /PRNewswire/ --...
Etcelera unites the platform technologies of Cellarity, Etiome, and Empress Therapeutics with Flagship Pioneering's proprietary AI capabilities to scale causal...
Partnership adds three family dental practices in West Bend, Jackson and Saukville, extending First Choice Dental's presence in southeastern WisconsinMADISON,...
Through a first-of-its-kind agent partnership, Instinct will use Zocdoc's healthcare access infrastructure to find vetted providers, verify insurance, and book...
Shipments to Peak Medical underway under agreement with multi-million-dollar minimum purchase commitments through 2029; follows September start of PainShield® shipments...
New research from Hopelab and the Center for Digital Thriving shares four insights from young people on how families can...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE:...
ExoCordOA, a five-year project, led by Exogenus Therapeutics and backed by Horizon Europe, brings together ten organisations spanning biotechnology, clinical...
Financing led by Asabys, with participation from CDTI with its SICC Innvierte and the Institut Català de Finances (ICF)Proceeds will...
Frank Berg Rasmussen Vice President of Portugal Manufacturing site Coloplast Coloplast's manufacturing site in Portugal Coloplast manufacturing site in Felgueiras...
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd. TME Pharma receives €150,000 for 6 months of...
The Board of Directors has resolved to pay an additional ordinary cash dividend of NOK 0.50 per share in November,...
Vistin Pharma ASA: Third quarter and YTD 2026 financial results Oslo, Norway, 29 October 2026 Vistin Pharma ASA (VISTN) today...
Cardiolyse ECG Workspace Doctor working in Cardiolyse ECG Workspace Cardiolyse CEO Cardiolyse CEO Cardiolyse Launches AI-Powered ECG Workspace for 12-Lead...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 29, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq:...
Ad hoc announcement pursuant to Art. 53 LR QUVIVIQâ„¢ (daridorexant) sales reached CHF 142 million in the first nine months...
Ad hoc announcement pursuant to Art. 53 LR Dedicated launch capital and shared participation in future revenues create a focused...